SCHEMBL23966847

SCHEMBL23966847

CONc1cc(Br)c(OCC2CC2)cc1N

nearest known ligand 0.40

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
AAK1 Q2M2I8 3/20 0.40
CNR2 P34972 1/20 0.38
SCN9A Q15858 2/20 0.35
PDE4B Q07343 8/20 0.33
PDE4A P27815 3/20 0.33
PDE4C Q08493 3/20 0.33
PDE4D Q08499 3/20 0.33
DHFR P00374 1/20 0.32
KDM4E B2RXH2 1/20 0.32
ALDH1A1 P00352 1/20 0.32
RIPK1 Q13546 1/20 0.32
PTGER4 P35408 1/20 0.31
HTR2A P28223 1/20 0.30
HTR2C P28335 1/20 0.30
HTR2B P41595 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23915570 0.80 CNR2 (0.39) AAK1CNR2SCN9ADHFRRIPK1
SCHEMBL23966851 0.80 TRPA1 (0.37) CNR2PDE4BPDE4APDE4CPDE4D
SCHEMBL29311606 0.75 HTR7 (0.44) KDM4EALDH1A1HTR2A
SCHEMBL16738735 0.74 MCHR1 (0.42) AAK1SCN9AHTR2C
SCHEMBL23966794 0.70 CNR2 (0.35) AAK1CNR2SCN9ADHFRRIPK1
SCHEMBL16650978 0.68 RIPK1 (0.41) RIPK1HTR2AHTR2CHTR2B
SCHEMBL23966507 0.68 KDM4E (0.39) KDM4EALDH1A1RIPK1HTR2AHTR2C
SCHEMBL983574 0.68 EGFR (0.39) PDE4BPDE4DHTR2AHTR2CHTR2B
SCHEMBL15871 0.68 HTR2A (0.40) CNR2PDE4BPDE4DKDM4EALDH1A1
SCHEMBL21957402 0.67 SCD (0.42) CNR2SCN9ARIPK1HTR2AHTR2C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3649119-B1 NOVEL COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS THEREOF FOR THE TREATMENT OF FIBROSIS GALAPAGOS NV (BE) 2021-11-03 EP disclosed